The inflammatory condition, which can be hard to diagnose, affects up to 1 in 10 women and treatment can be limited.
The new, double blind clinical trial will aim to discover if a novel immune-based treatment is able to treat severe endometriosis.
The trust is looking for women aged between 18 and 49 years who have a confirmed diagnosis and are willing to have laparoscopic surgery after study treatment.
